| |
| |
|
| Insider
Information: |
Aasen Thomas H |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,848 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$406,608 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
23,848 |
|
|
| Total
Value |
$406,608 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acadia Pharmaceuticals Inc |
ACAD |
|
2014-04-04 |
23,848 |
2014-04-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2014-04-04 |
4 |
GA |
$0.00 |
$0 |
I/I |
15,000 |
15,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2014-04-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
23,848 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2014-04-04 |
4 |
OE |
$1.55 |
$11,625 |
D/D |
7,500 |
38,848 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2014-04-04 |
4 |
AS |
$22.48 |
$337,260 |
I/I |
(15,000) |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2014-01-02 |
4 |
OE |
$1.55 |
$34,100 |
D/D |
22,000 |
61,348 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2014-01-02 |
4 |
AS |
$24.88 |
$746,334 |
I/I |
(30,000) |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2014-01-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
30,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2014-01-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
31,348 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-12-12 |
4 |
OE |
$1.55 |
$24,000 |
D/D |
12,000 |
39,348 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-12-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
27,348 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-10-01 |
4 |
AS |
$27.87 |
$836,121 |
I/I |
(30,000) |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-10-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
30,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-10-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
24,085 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-10-01 |
4 |
OE |
$1.55 |
$61,875 |
D/D |
22,500 |
54,085 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-08-13 |
4 |
AS |
$20.15 |
$1,209,180 |
I/I |
(60,000) |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-08-13 |
4 |
OE |
$1.55 |
$69,750 |
D/D |
45,000 |
91,585 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-08-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
60,000 |
31,585 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-08-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
60,000 |
60,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-04-11 |
4 |
AS |
$11.06 |
$442,400 |
I/I |
(40,000) |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-04-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
40,000 |
40,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-04-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
40,000 |
44,500 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-04-11 |
4 |
OE |
$1.08 |
$54,845 |
D/D |
34,029 |
84,500 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-04-01 |
4 |
OE |
$1.08 |
$43,200 |
D/D |
40,000 |
90,471 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-04-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
40,000 |
50,471 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EXEC VP, CFO AND CBO |
• – – |
2013-04-01 |
4 |
AS |
$7.68 |
$307,084 |
I/I |
(40,000) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
